SANTA MONICA, Calif., July 18, 2011 /PRNewswire/ -- Derycz Scientific, Inc. (OTC BB: DYSC) today announced that its wholly owned subsidiary Reprints Desk Inc. had signed sourcing and distribution agreements for scientific and medical PDF content from publishers Mary Ann Liebert Inc. and SLACK Incorporated. This agreement is expected to increase operational efficiencies and overall delivery speed for biomedical researchers who are among the heaviest users within Reprints Desk's base of corporate Life Science customers.
"Reprints Desk simplifies business processes for time-strapped researchers who buy content from these publishers and many others through Reprints Desk in support of important preclinical discovery work," said Derycz Scientific's Head of Publisher Relations, Jan Peterson. "This agreement is a win-win-win. Our customers benefit from even faster service, our publishing partners gain a deep channel into the corporate sector, and our company continues to improve its rapid sourcing capabilities."
Founded in 1980, Mary Ann Liebert, Inc. is universally acknowledged for publishing authoritative peer-reviewed journals, books, and trade magazines in the most promising areas of biotechnology, biomedical research/life sciences, clinical medicine and surgery, alternative and complementary medicine, law, philanthropy, environmental science and sustainability. SLACK Incorporated, with roots reaching back to 1923, is a leading provider of information to targeted health care specialties. SLACK's range of products include journals, books, and newspapers for the STM market.
About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, with services designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces and newsletters; and works with publishers who wish to outsource a portion of or all of their reprints business. TAAG offers printing, distribution and information logistics services, with core competencies in the professional production and distribution of clinical trial kits and clinical article reprints for the life sciences industry. For more information, please visit www.deryczscientific.com.
About Reprints Desk
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard. For more information about Reprints Desk, visit www.reprintsdesk.com.
Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.